In Vivo Model Systems in P-Glycoprotein-Mediated Multidrug Resistance

Author： Vrie Wim van de Marquet Richard L. Stoter Gerrit Bruijn Ernst A. De Eggermont Alexander M. M.

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.35, Iss.1, 1998-02, pp. : 1-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucose modulation induces reactive oxygen species and increases P‐glycoprotein‐mediated multidrug resistance to chemotherapeutics

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2557-2572

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically based pharmacokinetic modelling and in vivo [I]/Ki accurately predict P‐glycoprotein‐mediated drug‐drug interactions with dabigatran etexilate

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 1043-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P‐glycoprotein

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1010-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determination and Prediction of P-Glycoprotein and Multidrug-Resistance-Related Protein Expression in Breast Cancer with Double-Phase Technetium-99m Sestamibi Scintimammography

Oncology, Vol. 70, Iss. 6, 2007-02 ,pp. : 403-410

Karger

Access to resources Recommend Favorite

Human intestinal P-glycoprotein activity estimated by the model substrate digoxin

By Larsen U. L. Olesen Hyldahl Nyvold Guldborg Eriksen J. Jakobsen P. Østergaard M. Autrup H. Andersen V.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 2, 2007-01 ,pp. : 123-134

Informa Healthcare

Access to resources Recommend Favorite